New NASEM Report Suggests Dropping Race, Ethnicity Tags From Genetic, Genomic Studiesadminpmls20162023-03-15T08:16:03-05:00March 15th, 2023|Read More
Illumina Shares Soar as Billionaire Investor Seeks Board Seats to End Grail Takeover ‘Insanity’adminpmls20162023-03-15T08:08:47-05:00March 15th, 2023|Read More
New Single-Cell Genome, Transcriptome Sequencing Technique Delivers Better Bang For Buckadminpmls20162023-03-15T08:07:05-05:00March 15th, 2023|Read More
Sophia Genetics, Agilent Partner on Cancer Analysis Productadminpmls20162023-03-15T08:05:17-05:00March 15th, 2023|Read More
Polygenic Risk Score, AI Tool May Help Patients Reduce Inherited Heart Disease Risk, Study Suggestsadminpmls20162023-03-08T08:33:57-05:00March 8th, 2023|Read More
Newly Formed Velsera Seeks Additional Acquisitions to Build Precision Medicine Platformadminpmls20162023-03-08T08:29:50-05:00March 8th, 2023|Read More
SomaLogic Expands Into Middle East With Proteomics Supply Deal for Group 42 Healthcareadminpmls20162023-03-08T08:27:33-05:00March 8th, 2023|Read More
MolDx Reimbursement Decision Likely to Have Negative Impact on CareDx, Natera Transplant Businessesadminpmls20162023-03-08T08:25:21-05:00March 8th, 2023|Read More
VieCure, Exact Sciences Partner to Ease Genomic Testing Access, Interpretationadminpmls20162023-03-08T08:22:20-05:00March 8th, 2023|Read More
Sophia Genetics Q4 Revenues Grow 23 Percent on Strong Data Analysis Salesadminpmls20162023-03-08T08:20:04-05:00March 8th, 2023|Read More
Invitae’s PCM Assay for Minimal Residual Disease Detection Nabs Coverage by Blue Shield of Californiaadminpmls20162023-03-08T08:18:27-05:00March 8th, 2023|Read More
Caris to Provide Biomarker Discovery, Molecular Testing for Incyte Oncology Drug Developmentadminpmls20162023-03-08T08:16:41-05:00March 8th, 2023|Read More
Personalis, AstraZeneca Extend Collaboration Around Residual Cancer Detection Testadminpmls20162023-03-08T08:13:14-05:00March 8th, 2023|Read More
Blueprint Medicines Reports Second Quarter 2022 Resultsadminpmls20162022-08-10T21:02:03-05:00August 10th, 2022|Read More
GenomOncology and Congenica announce collaborative development of novel Precision Oncology Solutionadminpmls20162022-08-10T20:54:23-05:00August 10th, 2022|Read More
Metabolon Announces Joint Development Agreement with Mayo Clinic to Create New Diagnostic Testsadminpmls20162022-08-10T20:50:25-05:00August 10th, 2022|Read More
Bristol Myers Squibb and 2seventy bio Announce Topline Results from KarMMa-3 Trial Showing Abecma (idecabtagene vicleucel) Significantly Improves Progression-Free Survival Versus Standard Regimens in Relapsed and Refractory Multiple Myelomaadminpmls20162022-08-10T20:46:27-05:00August 10th, 2022|Read More
23andMe Pins Future on ‘Genomic Health Service,’ Therapeutic Developmentadminpmls20162022-08-10T20:42:15-05:00August 10th, 2022|Read More
Myocardial Infarction Features Found With Multiomic Molecular Mapadminpmls20162022-08-10T20:39:10-05:00August 10th, 2022|Read More
Beyond 1M Genomes Project Releases Recommendations to Guide European Genomic Data Initiativeadminpmls20162022-08-10T20:34:45-05:00August 10th, 2022|Read More
Oncology Business Pushes Invitae’s Q2 Revenues up 18 Percentadminpmls20162022-08-10T20:31:51-05:00August 10th, 2022|Read More
10x Genomics Lowers Full-Year 2022 Revenue Guidance by Approximately $100Madminpmls20162022-08-10T20:27:43-05:00August 10th, 2022|Read More
Mass General Program to Help Doctors Balance End-of-Life Talks With Precision Oncology Optimismadminpmls20162022-07-11T12:37:37-05:00July 11th, 2022|Read More
Doctors, Payors, Lab Directors, Patients Have Distinct Views on What’s Holding Up Precision Oncologyadminpmls20162022-07-11T09:36:56-05:00July 11th, 2022|Read More
MirXes, Singapore Healthcare Organizations Partner to Develop Multi-Cancer Early Detection Testadminpmls20162022-07-11T09:34:12-05:00July 11th, 2022|Read More
Helix Showcases New Population Genomics Method in Cardiomyopathy Risk Studyadminpmls20162022-07-11T09:32:40-05:00July 11th, 2022|Read More
Sequencing Firm Genapsys, Mired in Lawsuits, Explores Bankruptcyadminpmls20162022-07-11T09:28:31-05:00July 11th, 2022|Read More
SD Biosensor, SJL Partners to Acquire Meridian Bioscience for $1.5Badminpmls20162022-07-08T14:41:54-05:00July 8th, 2022|Read More
BillionToOne, UCSD Partner to Assess New Liquid Biopsy Assays in Lung Canceradminpmls20162022-07-08T13:31:42-05:00July 8th, 2022|Read More
Caris Life Sciences Expands Partnership With Epic to Improve Molecular Testing Accessadminpmls20162022-07-08T13:29:16-05:00July 8th, 2022|Read More
California Passes State Budget Including $19.3M for Precision Medicineadminpmls20162022-07-08T13:27:22-05:00July 8th, 2022|Read More
ESMO Releases Guidelines for Liquid Biopsy Testing in Cancer Patientsadminpmls20162022-07-08T13:11:42-05:00July 8th, 2022|Read More
SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnosticsadminpmls20162022-06-16T20:33:13-05:00June 16th, 2022|Read More
Tempus Announces Research Collaboration with Intermountain Healthcare to Advance Precision Oncology Researchadminpmls20162022-06-16T20:14:04-05:00June 16th, 2022|Read More
Bristol Myers Squibb Elects Deepak L. Bhatt, M.D., M.P.H. to Board of Directorsadminpmls20162022-06-16T20:10:01-05:00June 16th, 2022|Read More
Halo Diagnostics to Offer Genomic Testing Cooperative Genomic Profiling Testsadminpmls20162022-06-16T20:06:56-05:00June 16th, 2022|Read More
Thermo Fisher Scientific Receives CE-IVD Mark for NGS Aneuploidy Diagnostic Software Workflowsadminpmls20162022-06-16T20:04:58-05:00June 16th, 2022|Read More
Allen Institute, Google Release Multiomic Immunology Research Portaladminpmls20162022-06-16T17:37:13-05:00June 16th, 2022|Read More
Imagia Canexia Health Garners CE-IVD Mark for Comprehensive Cancer Testing Platformadminpmls20162022-06-16T17:33:32-05:00June 16th, 2022|Read More
Paige, Janssen Partner on Bladder Cancer Dxadminpmls20162022-06-16T17:32:07-05:00June 16th, 2022|Read More
Kidney Disease Targets Uncovered in Integrated Omics Analysisadminpmls20162022-06-16T13:43:55-05:00June 16th, 2022|Read More
Rady Children’s Institute for Genomic Medicine Partners With Inozyme Pharma on NGS Newborn Screeningadminpmls20162022-06-16T13:42:36-05:00June 16th, 2022|Read More
Lunaphore, Indica Labs Partner on Spatial Biology Workflowsadminpmls20162022-05-12T17:47:10-05:00May 12th, 2022|Read More
Coriell Life Sciences Wins Second MedTech Breakthrough Award for Genomics Innovationadminpmls20162022-05-12T10:31:15-05:00May 12th, 2022|Read More
Singular Genomics Systems Books No Revenues in Q1, Partners With Nvidia, Bio-Rad, Quantabioadminpmls20162022-05-12T10:28:49-05:00May 12th, 2022|Read More
Siemens Healthineers Set to Develop Next-Generation, High-Throughput MDx Platformadminpmls20162022-05-12T10:25:00-05:00May 12th, 2022|Read More
Thermo Fisher Scientific Invests in Spatial Proteomics Firm Ionpathadminpmls20162022-05-12T10:21:07-05:00May 12th, 2022|Read More
Roche Diagnostics Q1 Sales Up 22 Percentadminpmls20162022-04-25T11:09:25-05:00April 25th, 2022|Read More
Next PrecisionFDA Challenge Takes on Indel Calling from Oncopanel Sequencing Dataadminpmls20162022-04-25T11:12:11-05:00April 25th, 2022|Read More
NeoGenomics, Eli Lilly to Offer Molecular Testing to Non-Small Cell Lung Cancer Patientsadminpmls20162022-04-25T11:15:17-05:00April 25th, 2022|Read More
Yourgene Health, Ambry Genetics Team on Genomic Services Under Extended Strategic Partnershipadminpmls20162022-04-25T11:16:47-05:00April 25th, 2022|Read More
Tempus Sets Sights on Pathology Market With New Informatics, Research Networkadminpmls20162022-04-08T21:09:32-05:00April 8th, 2022|Read More
Qiagen Sues Bio-Rad Seeking Declaration of Non-Infringement of Digital PCR Patentsadminpmls20162022-04-08T21:03:41-05:00April 8th, 2022|Read More
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022adminpmls20162022-04-08T20:49:23-05:00April 8th, 2022|Read More
New Research from the Caris Precision Oncology Alliance Finds Prognostic and Predictive Drug-Induced Gene Signatures for Colorectal Cancer Patientsadminpmls20162022-04-08T20:45:40-05:00April 8th, 2022|Read More
Blueprint Medicines Expands Trials of EGFR Inhibitors in NSCLCadminpmls20162022-04-08T20:37:15-05:00April 8th, 2022|Read More
Single-Cell Sequencing Study Uncovers Blood Cell Type-Specific Featuresadminpmls20162022-04-08T20:32:18-05:00April 8th, 2022|Read More
New Liquid Biopsy Method Infers RNA Expression From DNA Fragmentation Analysisadminpmls20162022-04-08T20:30:02-05:00April 8th, 2022|Read More
YESCARTA® RECEIVES U.S. FDA APPROVAL AS FIRST CAR T-CELL THERAPY FOR INITIAL TREATMENT OF RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA (LBCL)adminpmls20162022-04-03T09:52:15-05:00April 3rd, 2022|Read More
BabySeq Newborn Screening Project Aims For Increased Diversity in Second Phaseadminpmls20162022-04-03T09:46:26-05:00April 3rd, 2022|Read More
SomaLogic Previews New Products, Global Expansion Coming in 2022adminpmls20162022-04-03T09:43:53-05:00April 3rd, 2022|Read More
Roche Expands Molecular Business With Digital PCR, Lower-Volume Cobas Instrumentsadminpmls20162022-03-24T18:04:22-05:00March 24th, 2022|Read More
FDA Approves Novartis Radiologand Pluvicto for PSMA-Positive mCRPC With Imaging CDxadminpmls20162022-03-24T18:00:37-05:00March 24th, 2022|Read More
LifeMine Therapeutics Nets $175M in Series C, Inks GSK Deal to Advance Genomically Informed Drugsadminpmls20162022-03-24T17:57:13-05:00March 24th, 2022|Read More
Researchers ID Gut Microbiome Impact on CAR T-Cell Therapy Outcomesadminpmls20162022-03-24T17:52:39-05:00March 24th, 2022|Read More
Australian Government Invests A$28.1M to Establish Genomics Agencyadminpmls20162022-03-24T17:48:26-05:00March 24th, 2022|Read More
Real-World Impact of Pharmacogenomics and Comprehensive Medication Management Revealed in New Coriell Life Sciences Case Studyadminpmls20162022-03-18T09:42:13-05:00March 18th, 2022|Read More
Labcorp Enters Into Strategic Relationship with Prisma Healthadminpmls20162022-03-18T09:37:36-05:00March 18th, 2022|Read More
New peer-reviewed research shows no increased risk of serious COVID-19 infections in Kesimpta® (ofatumumab)-treated adults with multiple sclerosisadminpmls20162022-03-18T09:34:39-05:00March 18th, 2022|Read More
Genomic Data Release Opens New Paths for Discoveryadminpmls20162022-03-18T09:30:41-05:00March 18th, 2022|Read More
NeoGenomics appoints Dr. Shashi Kulkarni, a World-Renowned Oncology Genomics Expert, and Innovator as Chief Scientific Officeradminpmls20162022-03-12T13:09:58-05:00March 12th, 2022|Read More
The Broad Institute Selects Fabric Genomics in Implementation of Clinical Whole Genome Sequencing Offeringadminpmls20162022-03-12T13:05:38-05:00March 12th, 2022|Read More
PathAI and Cleveland Clinic Announce Collaboration to Build Digital Pathology Infrastructure and Evolve Use of AI-Powered Pathology Algorithms in Research and Clinical Careadminpmls20162022-03-12T13:00:24-05:00March 12th, 2022|Read More
Genomenon Raises $20M Series B Financing, Launching a New Era in AI-Powered Genomic Dataadminpmls20162022-03-12T12:57:35-05:00March 12th, 2022|Read More
Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meetingadminpmls20162022-03-05T16:14:32-05:00March 5th, 2022|Read More
Quanterix Announces Executive Leadership Succession Planadminpmls20162022-03-05T16:00:20-05:00March 5th, 2022|Read More
NanoString Technologies Releases Fourth Quarter and Full Year 2021 Operating Results and Provides 2022 Financial Outlookadminpmls20162022-03-05T16:23:02-05:00March 5th, 2022|Read More
Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Resultsadminpmls20162022-03-05T15:54:57-05:00March 5th, 2022|Read More
CancerIQ Raises $14M Series B Funding to Improve Access to Innovations in Cancer Early Detection and Preventionadminpmls20162022-03-05T15:41:38-05:00March 5th, 2022|Read More
Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaborationadminpmls20162022-02-25T12:15:46-05:00February 25th, 2022|Read More
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) plus Chemotherapy for First-Line Treatmentadminpmls20162022-02-25T12:11:39-05:00February 25th, 2022|Read More
Fulgent Genetics Announces Strategic Investment in Spatial Genomicsadminpmls20162022-02-25T12:05:13-05:00February 25th, 2022|Read More
Scipher Medicine Closes $110 Million Financingadminpmls20162022-02-25T12:01:24-05:00February 25th, 2022|Read More
PrecisionLife announces appointment of Colin Stubberfield as SVP Drug Discovery to lead development of its precision medicine programsadminpmls20162022-02-21T09:05:47-05:00February 21st, 2022|Read More
Blueprint Medicines Reports Fourth Quarter and Full Year 2021 Resultsadminpmls20162022-02-18T08:58:43-05:00February 18th, 2022|Read More
Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Fundingadminpmls20162022-02-18T08:51:51-05:00February 18th, 2022|Read More
Synthego Raises $200 Million to Accelerate the Field of CRISPR-Based Medicines from Early-Phase Research to the Clinicadminpmls20162022-02-18T08:49:18-05:00February 18th, 2022|Read More
Precision Medicine Leader Scott Megill Named One of The Top 25 Biotech CEOs of 2022adminpmls20162022-02-17T11:19:39-05:00February 17th, 2022|Read More
Astra Zeneca Reports Full year and Q4 2021 resultsadminpmls20162022-02-10T17:34:06-05:00February 10th, 2022|Read More
Foundation Medicine Announces Global Collaboration With Lillyadminpmls20162022-02-10T17:29:24-05:00February 10th, 2022|Read More
Tempus Announces the Acquisition of Highline Sciencesadminpmls20162022-02-10T17:25:39-05:00February 10th, 2022|Read More
Element Biosciences Closes Acquisition of Loop Genomicsadminpmls20162022-02-10T17:23:41-05:00February 10th, 2022|Read More
OneOncology Names Dr. Davey Daniel as Chief Medical Officeradminpmls20162022-02-10T17:21:44-05:00February 10th, 2022|Read More
Fabric Genomics Appoints Industry Veteran Jyoti Palaniappan as Chief Commercial Officeradminpmls20162022-02-03T20:01:56-05:00February 3rd, 2022|Read More
MRM Proteomics, Inc. and Agilent Technologies, Inc.: A Collaboration for Progressadminpmls20162022-02-03T19:53:47-05:00February 3rd, 2022|Read More
Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage canceradminpmls20162022-02-03T19:49:41-05:00February 3rd, 2022|Read More
Novartis delivers mid single digit sales growth, margin expansion and advancement of robust pipeline in 2021adminpmls20162022-02-03T19:47:29-05:00February 3rd, 2022|Read More
Bristol Myers Squibb Receives Approval for Abecma (idecabtagene vicleucel), the First CAR T Therapy Approved for the Treatment of Multiple Myeloma in Japanadminpmls20162022-01-27T19:53:51-05:00January 27th, 2022|Read More
Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation genomics researchadminpmls20162022-01-27T19:47:21-05:00January 27th, 2022|Read More
Active Motif Incorporated Announces the Acquisition of Amaryllis Nucleics and their proprietary RNASeq workflowadminpmls20162022-01-27T19:43:42-05:00January 27th, 2022|Read More
Flatiron Health Announces RWD Partnership with Japan’s NCCHEadminpmls20162022-01-27T19:41:34-05:00January 27th, 2022|Read More
PGDx Announces an Updated Medicare Reimbursement Rate for the elio™ tissue complete Testadminpmls20162022-01-27T09:26:05-05:00January 27th, 2022|Read More
Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy® in Combination With KEYTRUDA® in First-Line Metastatic Non-Small Cell Lung Canceradminpmls20162022-01-19T19:14:56-05:00January 19th, 2022|Read More
Paige Announces Executive Leadership Appointmentsadminpmls20162022-01-19T19:10:10-05:00January 19th, 2022|Read More
M2GEN Expands Leadership Team, Appointing Daniel Elgort, Ph.D. as Chief Data and Analytics Officer and May Yoon as Chief People Officeradminpmls20162022-01-19T19:06:16-05:00January 19th, 2022|Read More
Blueprint Medicines Provides 2022 Portfolio Goals Targeting Expanded Precision Therapy Leadershipadminpmls20162022-01-19T19:03:43-05:00January 19th, 2022|Read More
Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platformadminpmls20162022-01-19T18:57:09-05:00January 19th, 2022|Read More
Almac Diagnostic Services’ claraT Report Assists Researchers In Uncovering New Oncology Findingsadminpmls20162022-01-13T23:00:44-05:00January 13th, 2022|Read More
GenomOncology Pathology Workbench to Support OmniSeq INSIGHT℠, a Genomic and Immune Profiling Test That Identifies Potential Treatment and Clinical Trial Options for Solid Tumorsadminpmls20162022-01-13T22:56:43-05:00January 13th, 2022|Read More
SOPHiA GENETICS Reports Strong Traction in the Launch Phase of its DEEP-Lung-IV Multimodal Clinical Studyadminpmls20162022-01-13T22:48:55-05:00January 13th, 2022|Read More
Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnershipadminpmls20162022-01-13T22:42:50-05:00January 13th, 2022|Read More
Bristol Myers Squibb to Highlight Long-Term Growth Strategy at J.P. Morgan’s 40th Annual Healthcare Conferenceadminpmls20162022-01-13T22:32:12-05:00January 13th, 2022|Read More
Coriell Life Sciences Achieves HITRUST CSF® Certification for GeneDose Live Clinical Decision Support Systemadminpmls20162022-01-10T12:03:10-05:00January 10th, 2022|Read More
Thermo Fisher Scientific Completes Acquisition of PeproTech, a Leader in Recombinant Proteinsadminpmls20162022-01-06T12:19:28-05:00January 6th, 2022|Read More
Novartis announces collaboration with Alnylam to explore targeted therapy to restore liver functionadminpmls20162022-01-06T11:44:06-05:00January 6th, 2022|Read More
RareCyte® Inc. reports significant 2021 growth of Precision Biology™ Services business and customer uptake of Orion™ Spatial Biology instruments and reagentsadminpmls20162022-01-06T11:40:22-05:00January 6th, 2022|Read More
DNA Script Closes $200 Million Series C Financing with Completion of Second Trancheadminpmls20162022-01-06T11:33:57-05:00January 6th, 2022|Read More
SomaLogic announces exclusive partnership with Illumina to develop sequencing-based proteomic solutionsadminpmls20162022-01-06T11:32:13-05:00January 6th, 2022|Read More
Labcorp Acquires Personal Genome Diagnosticsadminpmls20162021-12-23T11:27:21-05:00December 23rd, 2021|Read More
GenXys Inks Deal with Precision Genetics for Personalized Medicineadminpmls20162021-12-22T13:41:03-05:00December 22nd, 2021|Read More
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn’s Proprietary Gene Traffic Control® Platformadminpmls20162021-12-22T13:04:49-05:00December 22nd, 2021|Read More
Lonza and Agilent Announce Strategic Collaboration to Integrate New Analytical Technologies with Lonza’s Cocoon Platformadminpmls20162021-12-22T12:59:58-05:00December 22nd, 2021|Read More
Immatics and Bristol Myers Squibb Enter Into Global Exclusive License for Immatics’ TCR Bispecific Program IMA401adminpmls20162021-12-22T12:57:25-05:00December 22nd, 2021|Read More
Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021adminpmls20162021-12-22T12:55:02-05:00December 22nd, 2021|Read More
Roche launches comprehensive genomic profiling kit to expand access to personalized cancer researchadminpmls20162021-10-25T16:54:02-05:00October 25th, 2021|Read More
Illumina Appoints Bob Ragusa as Chief Executive Officer (CEO) of GRAILadminpmls20162021-10-15T09:54:53-05:00October 15th, 2021|Read More
PathAI Announces Strategic Partnership with Roche to Enable Development and Distribution of Digital Pathology Diagnosticsadminpmls20162021-10-15T09:25:57-05:00October 15th, 2021|Read More
Terasaki Institute for Biomedical Innovation Signs Agreement with Qatar Foundationadminpmls20162021-10-14T15:38:37-05:00October 14th, 2021|Read More
Pillar Biosciences to Collaborate with Labcorp on Precision Genomic Cancer Testing Using Next-Generation Sequencingadminpmls20162021-10-14T10:20:57-05:00October 14th, 2021|Read More
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Canceradminpmls20162021-10-14T10:04:13-05:00October 14th, 2021|Read More
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseasesadminpmls20162021-10-14T09:59:24-05:00October 14th, 2021|Read More
Caris Life Sciences and Ono Pharmaceutical Announce Strategic Collaborationadminpmls20162021-10-14T09:57:05-05:00October 14th, 2021|Read More
Bionano Genomics to Acquire BioDiscoveryadminpmls20162021-10-14T09:52:48-05:00October 14th, 2021|Read More
Lilly and Susan G. Komen® Partner to Address Disparities in Breast Cancer Outcomes Experienced By Black Womenadminpmls20162021-09-30T11:52:55-05:00September 30th, 2021|Read More
MD Anderson and Siemens Healthineers collaborating to enable consistent clinical implementation of quantitative MRIadminpmls20162021-09-30T11:47:11-05:00September 30th, 2021|Read More
OncoDNA teams up with SOPHiA GENETICS to enable laboratories to establish data-driven medicine as a standard of careadminpmls20162021-09-30T11:43:59-05:00September 30th, 2021|Read More
GenXys Partners with Helix on an Integrated, Population Health Focused Pharmacogenomic Solutionadminpmls20162021-09-30T11:38:59-05:00September 30th, 2021|Read More
Lantern Pharma Enters into Strategic Collaboration with Deep Lensadminpmls20162021-09-30T11:36:37-05:00September 30th, 2021|Read More
Thermo Fisher Scientific Opens Call for Grant Proposals to Fund Clinical Research in Hematology-oncologyadminpmls20162021-09-30T11:33:09-05:00September 30th, 2021|Read More
Lifebit raises $60m to make vital biomedical data securely accessible for life changing research worldwideadminpmls20162021-09-30T11:29:38-05:00September 30th, 2021|Read More
Personal Genome Diagnostics and Cleveland Clinic Collaborate to Expand Utility of Liquid Biopsy Applications in Oncology Clinical Researchadminpmls20162021-09-30T11:24:00-05:00September 30th, 2021|Read More
Tempus xF Liquid Biopsy Assay Demonstrates Extensive Analytical and Clinical Validity in npj Precision Oncology Studyadminpmls20162021-07-14T07:59:04-05:00July 14th, 2021|Read More
Novartis and Hewlett Packard Enterprise join forces to advance Novartis global health effortsadminpmls20162021-07-14T07:56:30-05:00July 14th, 2021|Read More
Dr. Eric Walk Joins PathAI as Chief Medical Officeradminpmls20162021-07-14T07:53:42-05:00July 14th, 2021|Read More
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editingadminpmls20162021-07-14T07:49:18-05:00July 14th, 2021|Read More
Thermo Fisher Scientific Expands Corporate Leadership Teamadminpmls20162021-07-11T18:47:39-05:00July 11th, 2021|Read More
Agilent Announces New SureSelect Human All Exon V8adminpmls20162021-06-04T13:53:57-05:00June 4th, 2021|Read More
New Research from Caris Life Sciences Finds Immunotherapy Resistance in Leiomyosarcomaadminpmls20162021-06-04T13:36:10-05:00June 4th, 2021|Read More
Labcorp to Introduce Combined Oncology Offering at 2021 ASCO® Annual Meetingadminpmls20162021-06-04T13:31:37-05:00June 4th, 2021|Read More
Novartis announces Tabrecta® first published overall survival and updated overall response data in patients with METex14 metastatic NSCLCadminpmls20162021-06-04T13:27:57-05:00June 4th, 2021|Read More
Bristol Myers Squibb Presents Data from CheckMate -648adminpmls20162021-06-04T13:24:13-05:00June 4th, 2021|Read More
PrecisionLife and Cyclica Sign Strategic Partnership Combining Leading Data-driven Biology and Chemistry Platforms to Create a Rapid Innovation Engine for Drug Discoveryadminpmls20162021-05-17T08:51:06-05:00May 17th, 2021|Read More
Novartis key growth drivers and launches continue momentum in Q1, maintaining confidence in growth. Group guidance for FY 2021 confirmed.adminpmls20162021-04-29T12:29:27-05:00April 29th, 2021|Read More
Geisinger awarded $3.6 million to study genetics of canceradminpmls20162021-04-29T12:07:14-05:00April 29th, 2021|Read More
Thermo Fisher Scientific Reports First Quarter 2021 Resultsadminpmls20162021-04-29T12:05:32-05:00April 29th, 2021|Read More
Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiativeadminpmls20162021-04-29T12:02:23-05:00April 29th, 2021|Read More
Bristol Myers Squibb Reports First Quarter Financial Results for 2021adminpmls20162021-04-29T12:00:12-05:00April 29th, 2021|Read More
Mission Bio Announces Yan Zhang as New CEOadminpmls20162021-04-09T09:21:40-05:00April 9th, 2021|Read More
Diagnostic Laboratory Services, Inc. (DLS) Launches New Precision Medicine Program with GenomOncology’s Pathology Workbenchadminpmls20162021-04-09T09:18:18-05:00April 9th, 2021|Read More
Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin Cancersadminpmls20162021-04-09T09:08:23-05:00April 9th, 2021|Read More
Invitae to acquire Genosity to accelerate access to personalized oncology testing worldwideadminpmls20162021-04-09T09:02:47-05:00April 9th, 2021|Read More
Magellan Rx Management and Trapelo Health to Offer Precision Oncology Platform for Next-Generation Careadminpmls20162021-04-09T08:58:24-05:00April 9th, 2021|Read More
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s and bluebird bio’s Abecma (idecabtagene vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myelomaadminpmls20162021-04-01T15:24:10-05:00April 1st, 2021|Read More
Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Testadminpmls20162021-04-01T15:20:10-05:00April 1st, 2021|Read More
SomaLogic, Leading AI-Data Driven Proteomics Platform for Advanced Research and Clinical applications, to Combine with CM Life Sciences II, to Drive Growth and Expand Technology Platformadminpmls20162021-04-01T15:16:55-05:00April 1st, 2021|Read More
Genome Medical Expands Board of Directors and Leadership Team as Demand for Genomics Telehealth Services Growsadminpmls20162021-04-01T15:13:13-05:00April 1st, 2021|Read More
Thermo Fisher Scientific Completes FDA Listing and Launches the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System for In Vitro Diagnostic Useadminpmls20162021-03-25T09:39:58-05:00March 25th, 2021|Read More
NeoGenomics Agrees to Acquire Trapelo Healthadminpmls20162021-03-25T06:22:20-05:00March 24th, 2021|Read More
Scipher Medicine Announces $82 Million Financingadminpmls20162021-03-24T08:10:05-05:00March 24th, 2021|Read More
PrecisionLife continues growth and expansion with acquisition of Danish genomic analytics innovator GenoKeyadminpmls20162021-03-24T08:08:10-05:00March 24th, 2021|Read More
Genomenon Completes $5.3M Financing Roundadminpmls20162021-03-17T08:53:11-05:00March 17th, 2021|Read More
Dr. Katharine Knobil Named Agilent’s First Chief Medical Officeradminpmls20162021-03-15T09:50:03-05:00March 15th, 2021|Read More
Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disordersadminpmls20162021-03-15T09:40:18-05:00March 15th, 2021|Read More
Healthcare Executive Martha R. Temple Joins Coriell Life Sciences Board of Directorsadminpmls20162021-03-12T15:19:17-05:00March 12th, 2021|Read More
Konica Minolta Precision Medicine collaborates with AWS to create the next generation of precision diagnosticsadminpmls20162021-03-11T12:00:11-05:00March 11th, 2021|Read More
Lilly’s bamlanivimab and etesevimab together reduced hospitalizations and death in Phase 3 trial for early COVID-19adminpmls20162021-03-11T08:18:47-05:00March 10th, 2021|Read More
Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotechadminpmls20162021-01-27T07:05:48-05:00January 27th, 2021|Read More
Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancersadminpmls20162021-01-27T07:04:00-05:00January 12th, 2021|Read More
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)adminpmls20162021-01-27T07:00:15-05:00November 17th, 2020|Read More
Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflowsadminpmls20162021-01-27T06:55:18-05:00November 12th, 2020|Read More
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platformadminpmls20162021-01-27T06:53:33-05:00November 12th, 2020|Read More
LUNGevity Foundation Launches Inhale for Life: Right Track Public Service and Social Media Campaign During Lung Cancer Awareness Monthadminpmls20162021-01-27T06:47:19-05:00November 12th, 2020|Read More
Caris Life Sciences Announces Huntsman Cancer Institute Joins its Precision Oncology Allianceadminpmls20162021-01-27T06:43:29-05:00November 12th, 2020|Read More
Exact Sciences to Acquire Thrive Earlier Detection, Becoming a Leader in Blood-Based, Multi-Cancer Screeningadminpmls20162021-01-27T06:35:21-05:00October 27th, 2020|Read More
19 Organizations from the Healthcare Community Unite to Form COVID-19 Testing Industry Consortiumadminpmls20162021-01-27T06:28:36-05:00October 1st, 2020|Read More
Sema4 Announces Collaboration with Janssen on Optimizing Oncology Clinical Trialsadminpmls20162021-01-27T06:26:55-05:00October 1st, 2020|Read More
Ionis and Genuity Science announce agreement designed to rapidly translate genomic insights into therapeuticsadminpmls20162021-01-27T06:16:12-05:00October 1st, 2020|Read More
Cancer Genomic Screening Program LC-SCRUM-Asia Adopts Latest Thermo Fisher Scientific NGS Solutionsadminpmls20162021-01-27T05:23:13-05:00October 1st, 2020|Read More
Lilly Oncology to Showcase New Data from Robust Cancer Research Pipeline at ESMO Virtual Congress 2020adminpmls20162021-01-27T05:18:57-05:00September 10th, 2020|Read More
FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Canceradminpmls20162021-01-27T05:13:33-05:00September 10th, 2020|Read More
Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio for Ion Torrent Genexus System*adminpmls20162021-01-27T05:13:39-05:00September 3rd, 2020|Read More
Blueprint Medicines Strengthens Leadership with Appointment of Fouad Namouni, M.D., as President, Research & Developmentadminpmls20162021-01-27T05:13:45-05:00September 3rd, 2020|Read More
U.S. Food and Drug Administration Approves Onureg® (azacitidine tablets), a New Oral Therapy, as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemiaadminpmls20162021-01-27T05:13:50-05:00September 3rd, 2020|Read More
